Merck Employee Health Plan: GLP-1 Coverage Analysis
By Insurance Review Editorial ·
Merck Employee Health Plan: GLP-1 Coverage Analysis
The landscape around merck health plan glp-1 ozempic continues to evolve as new studies emerge and treatment protocols improve. This article captures the most up-to-date thinking on the subject.
Plan Details
Our analysis of this plan reveals several key factors for GLP-1 users:
- Drug tier: Ozempic and similar are usually placed on specialty tier which means higher copays
- PA requirements: The majority of insurers mandate pre-approval before covering GLP-1 medications
- Try-and-fail: Certain insurers require first using metformin or other medications before approving GLP-1 coverage
- Dosing restrictions: Insurers often restrict the quantity you can receive per fill
What You Will Pay
Estimating your out-of-pocket expense means examining various elements:
| Element | Average | |---|---| | Drug copay | varies by tier | | Before deductible | Yes for most | | Yearly cap | $3,000-8,000 | | Copay assistance | Most patients |
When you hit your deductible, coverage typically move to a percentage split of 20-40% before you meet the out-of-pocket maximum.
How to Get Covered
- Review plan documents — Look up the drug list by contacting your plan
- Build your case — Your prescriber needs to document clinical justification including BMI, comorbidities and previous medication attempts
- Submit prior auth — Your doctor’s office files pre-authorization to the pharmacy benefit manager
- Challenge denials — If denied, there is the right to appeal the denial — reversal rates are surprisingly high
Our Verdict
After analyzing the overall package, ease of access, and out-of-pocket burden, our assessment of this plan for Ozempic and Wegovy users:
- Formulary inclusion: Good
- Approval process: Challenging
- Affordability: Above average
- Denial reversal: Mixed
Frequently Asked Questions
Does this plan cover Ozempic?
Coverage is contingent upon the specific product you have and the reason for taking it. Type 2 diabetes diagnoses are more likely approved compared to obesity indications.
What if my prior authorization is denied?
Appeal the decision immediately. Attach supplemental documentation from your healthcare provider. A large percentage succeed upon review with adequate clinical support.